Surgical approach to fragility fractures: problems and perspectives

Area of Science:

• Orthopedics
• Bone Metabolism
• Geriatric Medicine

Background:

• Osteoporosis is a growing global health concern, characterized by decreased bone quality and increased fracture risk.
• Fragility fractures, a major consequence of osteoporosis, often result in significant disability and reduced patient independence.
• Current orthopedic fixation methods face challenges in achieving durable results in osteoporotic bone.

Purpose of the Study:

• To evaluate the efficacy of teriparatide as a bone-forming agent in patients with osteoporotic fragility fractures.
• To assess the impact of teriparatide on bone healing and surgical outcomes in this patient population.
• To explore novel therapeutic strategies for improving the quality of life for individuals with osteoporotic fractures.

Main Methods:

• Retrospective analysis of surgical patients treated for fragility fractures.
• Administration of teriparatide as an adjuvant therapy to enhance bone formation.
• Monitoring of patient response, bone healing, and surgical outcomes.

Main Results:

• Patients receiving teriparatide demonstrated improved bone healing.
• Surgical outcomes were positively influenced by the use of this bone-forming agent.
• Teriparatide showed potential in enhancing bone quality and implant integration.

Conclusions:

• Teriparatide represents a promising therapeutic option for managing osteoporotic fragility fractures.
• This bone-forming agent can aid orthopedic surgeons in improving surgical success and patient recovery.
• Further research into optimizing teriparatide use in fracture management is warranted.